USMD Hospital at Arlington is First Hospital in the World to Utilize Arena-C® HA Enhanced Cervical Intervertebral Body Fusio...
26 Marzo 2015 - 2:00PM
Business Wire
Jacob Rosenstein, M.D., Performed Surgery on
March 11, 2015
USMD Holdings, Inc. (NASDAQ: USMD), a physician-led integrated
healthcare system, announced today that Jacob Rosenstein, M.D., an
active staff member of USMD Hospital at Arlington, became the first
surgeon in the world to implant an Arena-C® HA with PEEK-OPTIMA® HA
Enhanced. This cervical spinal implant is designed to provide
mechanical stability and quicker healing for patients who need
spine surgery. Dr. Rosenstein completed the surgery on March 11,
2015, at USMD Hospital at Arlington.
The Arena-C HA with PEEK-OPTIMA HA Enhanced, which is
manufactured by SpineFrontier®, is a spinal implant device that is
produced with a revolutionary new biomaterial to enhance spinal
fusion technology. Dr. Rosenstein utilized the implant in an
anterior cervical discectomy and fusion procedure to treat a
patient who was suffering from spinal cord compression and
myelopathy as a result of degenerative disc disease that was
producing severe cervical stenosis.
PEEK-OPTIMA HA Enhanced shares all of the properties of
PEEK-OPTIMA Natural, which aids in stabilizing the cervical spine,
but it has been compounded with hydroxyapatite (HA), a naturally
occurring compound in bony structures. HA promotes the formation of
a direct interface between the implant and bone, without
intervening soft tissue. This is the first implant to be made with
HA, and was approved for use by the FDA in October 2014.
“The Arena-C HA with PEEK-OPTIMA is a potential game changer for
spinal fusion procedures,” said Jacob Rosenstein, M.D. “By
incorporating HA, a naturally occurring compound in bony
structures, into the PEEK Cage, fusion rate will improve, as HA
promotes direct attachment of the implant to the bone, thus
providing added stability and quicker healing. The device also has
a tapered design for easier insertion, a large bone graft pocket to
promote bone fusion and aggressive teeth to prevent expulsion. This
is a great benefit to patients, who will heal faster and more
predictably and return to normal activity sooner.”
“USMD is honored to be the first hospital in the world in which
one of our staff physicians conducted a surgery that utilizes the
new Arena-C HA spinal implant in a patient,” said John House, M.D.,
chairman of the board and chief executive officer of USMD Holdings.
“This is just one more example of the excellence of the physicians
and staff working at USMD Hospital at Arlington.”
Dr. Rosenstein is a board-certified neurosurgeon who specializes
in treating disorders of the spine. He earned his B.A. in Human
Biology from Johns Hopkins University. He completed his medical
degree from the Johns Hopkins University School of Medicine and his
residency in Neurological Surgery at U.T. Southwestern Medical
Center and Parkland Hospital in Dallas, where he served as Chief
Resident of Neurological Surgery. He completed his fellowship in
Neurological Surgery at the Gough-Cooper Department of Neurology
and Neurosurgery at the National Hospital for Nervous Diseases in
London, England. He has more than 30 years of experience caring for
patients. Dr. Rosenstein serves as a member of the USMD Hospital at
Arlington Board of Directors and was one of the hospital’s founding
physicians.
About USMD Holdings, Inc.
USMD is a publicly held (NASDAQ: USMD), physician-led,
integrated health system committed to exemplary patient care.
Headquartered in Irving, Texas, USMD serves the Dallas-Fort Worth
metropolitan area with more than 250 physicians and associate
practitioners, and provides healthcare services to patients in just
under 20 different specialties at its two hospitals, six cancer
treatment centers and nearly 70 physician clinics, many of which
are multi-specialty. All 29 of USMD’s primary care clinics have
been accredited by the Patient-Centered Medical Home Program, a
recognition program that is part of the National Committee for
Quality Assurance. This recognition means that USMD’s primary care
clinics successfully display and utilize evidence-based,
patient-centered processes that focus on highly coordinated patient
care and long-term patient relationships. For more information
about USMD, visit www.usmd.com.
About USMD Hospital at Arlington
USMD Hospital at Arlington is a physician-owned hospital where
clinical and surgical excellence are the everyday standards. With
nine oversized state-of-the-art operating rooms and two procedural
rooms, USMD Hospital at Arlington is equipped for a wide variety of
cases. The extensive surgical experience and expertise with three
da Vinci Systems has made USMD Hospital at Arlington a leader in
the DFW Metroplex, and one of the top ten robotic surgery programs
in the world. If an overnight stay is required, the hospital offers
34 private inpatient suites complete with WiFi, a small
refrigerator, TV and an additional bed for an attending family
visitor. What further differentiates this hospital from its
competitors is its 1:5 nurse to patient ratio versus the national
average of 1:8.
USMD Holdings, Inc.Megan Vincent,
214-493-4024Megan.Vincent@usmd.com
Grafico Azioni Usmd Holdings, Inc. (MM) (NASDAQ:USMD)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Usmd Holdings, Inc. (MM) (NASDAQ:USMD)
Storico
Da Set 2023 a Set 2024